These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35736245)

  • 41. NY-ESO-1/LAGE-1 coexpression with MAGE-A cancer/testis antigens: a tissue microarray study.
    Bolli M; Schultz-Thater E; Zajac P; Guller U; Feder C; Sanguedolce F; Carafa V; Terracciano L; Hudolin T; Spagnoli GC; Tornillo L
    Int J Cancer; 2005 Jul; 115(6):960-6. PubMed ID: 15751033
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
    Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
    Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of the NY-ESO-1 in the prognosis of gastric cancer.
    Misir Z; Glavčić G; Janković S; Kruljac I; Čugura Filipović J; Čimić K; Ulamec M
    Biomol Biomed; 2023 Dec; 24(4):813-820. PubMed ID: 38153439
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MAGE-A is More Highly Expressed Than NY-ESO-1 in a Systematic Immunohistochemical Analysis of 3668 Cases.
    Kerkar SP; Wang ZF; Lasota J; Park T; Patel K; Groh E; Rosenberg SA; Miettinen MM
    J Immunother; 2016 May; 39(4):181-7. PubMed ID: 27070449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistochemical expression of tumor antigens MAGE-A1, MAGE-A3/4, and NY-ESO-1 in squamous cell carcinoma of the penis.
    Hudolin T; Juretic A; Pasini J; Tomas D; Spagnoli GC; Heberer M; Dimanovski J; Kruslin B
    Urology; 2006 Jul; 68(1):205-7. PubMed ID: 16806422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control study.
    Forchhammer S; Pop OT; Hahn M; Aebischer V; Seitz CM; Schroeder C; Liebmann A; Abele M; Wild H; Bien E; Kunc M; Schneider DT; Cuk K; Büttel I; Flemmig C; Peters M; Laible M; Brück P; Türeci Ö; Sahin U; Flatz L; Brecht IB
    Virchows Arch; 2024 Aug; 485(2):335-346. PubMed ID: 38890171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Possible predictive role of cancer/testis antigens in breast ductal carcinoma
    Roguljic A; Spagnoli G; Juretic A; Sarcevic B; Banovic M; Beketic Oreskovic L
    Oncol Lett; 2018 Dec; 16(6):7245-7255. PubMed ID: 30546463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets.
    Xiao J; Huang F; Li L; Zhang L; Xie L; Liu B
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15003-15011. PubMed ID: 37610673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.
    John T; Starmans MH; Chen YT; Russell PA; Barnett SA; White SC; Mitchell PL; Walkiewicz M; Azad A; Lambin P; Tsao MS; Deb S; Altorki N; Wright G; Knight S; Boutros PC; Cebon JS
    PLoS One; 2013; 8(7):e67876. PubMed ID: 23935846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7.
    Jungbluth AA; Antonescu CR; Busam KJ; Iversen K; Kolb D; Coplan K; Chen YT; Stockert E; Ladanyi M; Old LJ
    Int J Cancer; 2001 Oct; 94(2):252-6. PubMed ID: 11668506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing.
    Bao L; Dunham K; Lucas K
    Cancer Immunol Immunother; 2011 Sep; 60(9):1299-307. PubMed ID: 21626030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination.
    Kawada J; Wada H; Isobe M; Gnjatic S; Nishikawa H; Jungbluth AA; Okazaki N; Uenaka A; Nakamura Y; Fujiwara S; Mizuno N; Saika T; Ritter E; Yamasaki M; Miyata H; Ritter G; Murphy R; Venhaus R; Pan L; Old LJ; Doki Y; Nakayama E
    Int J Cancer; 2012 Feb; 130(3):584-92. PubMed ID: 21413013
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
    Dhodapkar MV; Osman K; Teruya-Feldstein J; Filippa D; Hedvat CV; Iversen K; Kolb D; Geller MD; Hassoun H; Kewalramani T; Comenzo RL; Coplan K; Chen YT; Jungbluth AA
    Cancer Immun; 2003 Jul; 3():9. PubMed ID: 12875607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of NY-ESO-1, MAGE-A3, PRAME and WT1 in different subgroups of breast cancer: An indication to immunotherapy?
    Tessari A; Pilla L; Silvia D; Duca M; Paolini B; Carcangiu ML; Mariani L; de Braud FG; Cresta S
    Breast; 2018 Dec; 42():68-73. PubMed ID: 30189381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Investigation of melanoma-associated antigen A4 cancer/testis antigen clinical relevance in esophageal squamous cell carcinoma.
    Sani SA; Forghanifard MM; Sharifi N; Bidokhti MH; Bagherpoor AJ; Abbaszadegan MR
    J Cancer Res Ther; 2018; 14(5):1059-1064. PubMed ID: 30197348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Analysis of CT antigen expression and humoral immunogenicity of NY-ESO-1 protein in gastric carcinoma].
    Wu XJ; Wang Y; Ji JF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):252-6. PubMed ID: 15968313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.
    Stockert E; Jäger E; Chen YT; Scanlan MJ; Gout I; Karbach J; Arand M; Knuth A; Old LJ
    J Exp Med; 1998 Apr; 187(8):1349-54. PubMed ID: 9547346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of cancer-testis antigens in esophageal cancer and their progress in immunotherapy.
    Zhang Y; Zhang Y; Zhang L
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):281-291. PubMed ID: 30656409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma.
    Zhou JX; Li Y; Chen SX; Deng AM
    J Exp Clin Cancer Res; 2011 Jan; 30(1):2. PubMed ID: 21211023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
    Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
    Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.